Cargando…
Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species
Microglia activation and proliferation are hallmarks of many neurodegenerative disorders and may contribute to disease pathogenesis. Neurons actively regulate microglia survival and function, in part by secreting the microglia mitogen interleukin (IL)-34. Both IL-34 and colony stimulating factor (CS...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664563/ https://www.ncbi.nlm.nih.gov/pubmed/34899694 http://dx.doi.org/10.3389/fimmu.2021.734349 |
_version_ | 1784613870255472640 |
---|---|
author | Soto-Diaz, Katiria Vailati-Riboni, Mario Louie, Allison Y. McKim, Daniel B. Gaskins, H. Rex Johnson, Rodney W. Steelman, Andrew J. |
author_facet | Soto-Diaz, Katiria Vailati-Riboni, Mario Louie, Allison Y. McKim, Daniel B. Gaskins, H. Rex Johnson, Rodney W. Steelman, Andrew J. |
author_sort | Soto-Diaz, Katiria |
collection | PubMed |
description | Microglia activation and proliferation are hallmarks of many neurodegenerative disorders and may contribute to disease pathogenesis. Neurons actively regulate microglia survival and function, in part by secreting the microglia mitogen interleukin (IL)-34. Both IL-34 and colony stimulating factor (CSF)-1 bind colony stimulating factor receptor (CSFR)1 expressed on microglia. Systemic treatment with central nervous system (CNS) penetrant, CSFR1 antagonists, results in microglia death in a dose dependent matter, while others, such as GW2580, suppress activation during disease states without altering viability. However, it is not known how treatment with non-penetrant CSF1R antagonists, such as GW2580, affect the normal physiology of microglia. To determine how GW2580 affects microglia function, C57BL/6J mice were orally gavaged with vehicle or GW2580 (80mg/kg/d) for 8 days. Body weights and burrowing behavior were measured throughout the experiment. The effects of GW2580 on circulating leukocyte populations, brain microglia morphology, and the transcriptome of magnetically isolated adult brain microglia were determined. Body weights, burrowing behavior, and circulating leukocytes were not affected by treatment. Analysis of Iba-1 stained brain microglia indicated that GW2580 treatment altered morphology, but not cell number. Analysis of RNA-sequencing data indicated that genes related to reactive oxygen species (ROS) regulation and survival were suppressed by treatment. Treatment of primary microglia cultures with GW2580 resulted in a dose-dependent reduction in viability only when the cells were concurrently treated with LPS, an inducer of ROS. Pre-treatment with the ROS inhibitor, YCG063, blocked treatment induced reductions in viability. Finally, GW2580 sensitized microglia to hydrogen peroxide induced cell death. Together, these data suggest that partial CSF1R antagonism may render microglia more susceptible to reactive oxygen and nitrogen species. |
format | Online Article Text |
id | pubmed-8664563 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86645632021-12-11 Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species Soto-Diaz, Katiria Vailati-Riboni, Mario Louie, Allison Y. McKim, Daniel B. Gaskins, H. Rex Johnson, Rodney W. Steelman, Andrew J. Front Immunol Immunology Microglia activation and proliferation are hallmarks of many neurodegenerative disorders and may contribute to disease pathogenesis. Neurons actively regulate microglia survival and function, in part by secreting the microglia mitogen interleukin (IL)-34. Both IL-34 and colony stimulating factor (CSF)-1 bind colony stimulating factor receptor (CSFR)1 expressed on microglia. Systemic treatment with central nervous system (CNS) penetrant, CSFR1 antagonists, results in microglia death in a dose dependent matter, while others, such as GW2580, suppress activation during disease states without altering viability. However, it is not known how treatment with non-penetrant CSF1R antagonists, such as GW2580, affect the normal physiology of microglia. To determine how GW2580 affects microglia function, C57BL/6J mice were orally gavaged with vehicle or GW2580 (80mg/kg/d) for 8 days. Body weights and burrowing behavior were measured throughout the experiment. The effects of GW2580 on circulating leukocyte populations, brain microglia morphology, and the transcriptome of magnetically isolated adult brain microglia were determined. Body weights, burrowing behavior, and circulating leukocytes were not affected by treatment. Analysis of Iba-1 stained brain microglia indicated that GW2580 treatment altered morphology, but not cell number. Analysis of RNA-sequencing data indicated that genes related to reactive oxygen species (ROS) regulation and survival were suppressed by treatment. Treatment of primary microglia cultures with GW2580 resulted in a dose-dependent reduction in viability only when the cells were concurrently treated with LPS, an inducer of ROS. Pre-treatment with the ROS inhibitor, YCG063, blocked treatment induced reductions in viability. Finally, GW2580 sensitized microglia to hydrogen peroxide induced cell death. Together, these data suggest that partial CSF1R antagonism may render microglia more susceptible to reactive oxygen and nitrogen species. Frontiers Media S.A. 2021-11-26 /pmc/articles/PMC8664563/ /pubmed/34899694 http://dx.doi.org/10.3389/fimmu.2021.734349 Text en Copyright © 2021 Soto-Diaz, Vailati-Riboni, Louie, McKim, Gaskins, Johnson and Steelman https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Soto-Diaz, Katiria Vailati-Riboni, Mario Louie, Allison Y. McKim, Daniel B. Gaskins, H. Rex Johnson, Rodney W. Steelman, Andrew J. Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species |
title | Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species |
title_full | Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species |
title_fullStr | Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species |
title_full_unstemmed | Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species |
title_short | Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species |
title_sort | treatment with the csf1r antagonist gw2580, sensitizes microglia to reactive oxygen species |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664563/ https://www.ncbi.nlm.nih.gov/pubmed/34899694 http://dx.doi.org/10.3389/fimmu.2021.734349 |
work_keys_str_mv | AT sotodiazkatiria treatmentwiththecsf1rantagonistgw2580sensitizesmicrogliatoreactiveoxygenspecies AT vailatiribonimario treatmentwiththecsf1rantagonistgw2580sensitizesmicrogliatoreactiveoxygenspecies AT louieallisony treatmentwiththecsf1rantagonistgw2580sensitizesmicrogliatoreactiveoxygenspecies AT mckimdanielb treatmentwiththecsf1rantagonistgw2580sensitizesmicrogliatoreactiveoxygenspecies AT gaskinshrex treatmentwiththecsf1rantagonistgw2580sensitizesmicrogliatoreactiveoxygenspecies AT johnsonrodneyw treatmentwiththecsf1rantagonistgw2580sensitizesmicrogliatoreactiveoxygenspecies AT steelmanandrewj treatmentwiththecsf1rantagonistgw2580sensitizesmicrogliatoreactiveoxygenspecies |